Paul Tudor Jones's HRMY Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 38,534 shares of Harmony Biosciences Holdings, Inc. (HRMY) worth $1.08 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in HRMY, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 32,273 shares. Largest reduction occurred in Q1 2024, reducing 32,273 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Harmony Biosciences Holdings (HRMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Harmony Biosciences Holdings (HRMY) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +9,732 | Add 33.79% | 38,534 | $28.01 |
| Q4 2025 | +28,802 | New Buy | 28,802 | $37.42 |
| Q1 2024 | -32,273 | Sold Out | 0 | $0.00 |
| Q4 2023 | +32,273 | New Buy | 32,273 | $32.30 |
| Q3 2023 | -30,142 | Sold Out | 0 | $0.00 |
| Q2 2023 | +371 | Add 1.25% | 30,142 | $35.19 |
| Q1 2023 | +29,771 | New Buy | 29,771 | $0.03 |
| Q4 2020 | -6,236 | Sold Out | 0 | $0.00 |
| Q3 2020 | +6,236 | New Buy | 6,236 | $33.84 |
Paul Tudor Jones's Harmony Biosciences Holdings Investment FAQs
Paul Tudor Jones first purchased Harmony Biosciences Holdings, Inc. (HRMY) in Q3 2020, acquiring 6,236 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Harmony Biosciences Holdings, Inc. (HRMY) for 9 quarters since Q3 2020.
Paul Tudor Jones's largest addition to Harmony Biosciences Holdings, Inc. (HRMY) was in Q4 2023, adding 32,273 shares worth $1.04 M.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 38,534 shares of Harmony Biosciences Holdings, Inc. (HRMY), valued at approximately $1.08 M.
As of the Q1 2026 filing, Harmony Biosciences Holdings, Inc. (HRMY) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Harmony Biosciences Holdings, Inc. (HRMY) was 38,534 shares, as reported at the end of Q1 2026.